Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS) …

T Indran, T Das, J Muirhead, M O'Brien, MI Swain… - Leukemia Research, 2024 - Elsevier
Introduction This longitudinal study was based on the outcomes of Donor Lymphocyte
Infusion (DLI) for falling peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) …
相关文章

Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS) …

T Indran, T Das, J Muirhead, M O'Brien… - Leukemia …, 2024 - europepmc.org
Methods From 2012 to 2018, data was collected from the BMT database and electronic
medical records (EMR). The primary objective was to compare the indication for DLI based …

Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS) …

T Indran, T Das, J Muirhead, M O'Brien… - Leukemia … - pubmed.ncbi.nlm.nih.gov
Introduction This longitudinal study was based on the outcomes of Donor Lymphocyte
Infusion (DLI) for falling peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) …